- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Pharmaceutical and Medical Device
Events 43 results
Webinar
June 25, 2026
DOJ’s Evolving Enforcement Playbook in Life Sciences
Webinar
June 23, 2026
Fundamentals of EU Pharmaceutical Law
Webinar
May 20, 2026
Clinical Trials Under the Microscope: Navigating FDA’s New Rules and DOJ Enforcement
Webinar
April 27, 2026
Securities Litigation and Life Sciences: A Review of the Risks Facing Manufacturers of FDA-Regulated Drugs and Medical Devices
Webinar
April 23, 2026
AI in EU Pharma: Navigating Efficiency, Innovation and Regulatory Challenges
Webinar
March 12, 2026
Key Revisions of the EU General Pharmaceutical Legislation
Webinar
February 24, 2026
Reading the Tea Leaves: Top 10 Enforcement and Regulatory Risks for Device Makers in 2026
Speaking Engagement
December 8, 2025
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA program
Webinar
November 20, 2025
Pricing and Reimbursement in Europe
Conference
November 13, 2025
Medical Device Forum
Webinar
September 17, 2025
Advertising and Promotion of Medicinal Products
Speaking Engagement
September 12, 2025
Julia Zousmer to Speak at the American Law Institute’s MDL in Motion: Evolving Practices, Emerging Leaders, and Reform program